Testing effectiveness (Phase 2)Ended earlyNCT02792192
What this trial is testing
Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants
Who this might be right for
Bladder Cancer
Hoffmann-La Roche 24